Client Challenge
The client was a US based medical technology company which develops, manufactures and sells medical supplies, devices, laboratory instruments, antibodies, reagents and diagnostic products
In India, it operated through a wholly-owned subsidiary with a manufacturing facility at Bawal, Haryana. The client wanted to assess opportunity in India for its diagnostics segment with a focus on Tuberculosis (TB), Hospital Acquired Infections (HAI), The top management hired UC STRATEGY to assist in conducting this research and provide a perspective on the market by assessing facts and other dynamics in 10 shortlisted cities within India
Our Approach
In order to conduct a market assessment, UC STRATEGY used the following approach:
- Interviewed more than 80 respondents spread across 10 cities from various institutions such as standalone labs, private hospitals, government hospitals and private independent clinics
- The opportunity assessment for BD in the diagnostics segment was evaluated under 3 broad categories :
- Analysis of the diseases and their current burden in India
- Develop the diagnostic landscape
- Develop insights
- Conducted a detailed diagnostics overview of TB, HAI and Cervical Cancer
- Surveyed and examined the different lab model in India
- Assessed the Volumes processed and equipment procurement habits of labs
- Assessed the current prices and preferred prices
- Assessed the key concerns and examined the key success factors in this market
- Examined the key unmet needs for TB testing as expressed by labs
- Assessed the brand perception and brand recall of the players involved in the market
- Charted out the initiative for the client to be adopted in the market.
Our Impact
The client was submitted a final report of the Indian market assessment with a way forward planning and steps to be initiated.